Unknown OBSERVATIONAL NCT03752983

Chemokine (CXCL13) as Anew Marker in Diagnosis of SLE

Chemokine CXCL13 as a Marker of Disease Activity in Systemic Lupus Erythematosus

Sponsor: Assiut University

Updated 5 times since 2018 Last updated: Jan 27, 2019 Started: Mar 1, 2019 Primary completion: Mar 1, 2020 Completion: Dec 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Systemic Lupus, this trial is ongoing. The trial is conducted by Assiut University and has accumulated 5 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Feb 2019 — Jan 2021 [monthly]

Not Yet Recruiting
Dec 2018 — Feb 2019 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.